
Piedmont Heart Institute has named Andrew Boyle, M.D. as the new medical director for its Advanced Heart Failure Center. As Piedmont continues to grow its advanced heart failure program, Dr. Boyle oversees the medical management of heart transplant, mechanical circulatory support, heart failure and cardiomyopathy patients. He most recently oversaw the heart transplant program at the Cleveland Clinic Florida.
“Piedmont Heart Institute has taken an aggressive approach in fulfilling the critical need for advanced heart failure services in the southeast,” said Charles Brown III, M.D., chief of cardiovascular services for Piedmont Heart Institute. “In just a few short years our talented team has established one of the most successful mechanical circulatory support programs in the country and expanded our transplant services to include heart. Dr. Boyle’s leadership will help ensure Piedmont Heart Institute continues to grow as a recognized leader not only in the southeast, but across the United States as well.”
According to the American College of Cardiology, despite major improvements in the treatment of most cardiac disorders, heart failure remains a challenge and is the most common cause of hospitalization. Advanced heart failure centers like Piedmont enable physicians to focus on their specialties and provide the latest technologies and therapies to patients with complex and life-threatening heart disease.
Dr. Boyle comes to Piedmont from the Cleveland Clinic Florida, where he oversaw the heart transplant program and served as chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine Center and director of the Heart and Vascular Institute.
After earning his medical degree from the University of Ottawa in Ontario, Canada. Dr. Boyle completed his internal medicine residency at the Mayo Clinic in Rochester, Minnesota and fellowships in cardiovascular disease and heart failure transplantation at the Cleveland Clinic Foundation in Cleveland, Ohio.
Dr. Boyle is certified by the American Board of Internal Medicine in both cardiovascular disease and heart failure and transplant cardiology. He is also a member of the Heart Failure Society of America and the International Society of Heart and Lung Transplant.